Michael P. Hite
Keine laufenden Positionen mehr
Profil
Michael P.
Hite was the founder who founded Impel Pharmaceuticals, Inc. in 2008 and served as its Chief Executive Officer from 2008 to 2011.
He also worked as a Principal at SCOLR Pharma, Inc.
Ehemalige bekannte Positionen von Michael P. Hite
| Unternehmen | Position | Ende |
|---|---|---|
| SCOLR PHARMA INC. | Corporate Officer/Principal | - |
| IPI LEGACY LIQUIDATION CO | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| Private Unternehmen | 1 |
|---|---|
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
